Skip to main content

How ASPR and Industry Are Strengthening Medical Supply Chains Before the Next Emergency

When a hurricane threatens a manufacturing plant, Americans still need the medicines and medical supplies it produces. Preparing for that disruption requires preparation long before a storm forms. Whether the threat is a natural disaster, an interruption in overseas production, or a pandemic that sharply increases demand, government and industry must plan together to identify products at risk and keep production moving.

The Administration for Strategic Preparedness and Response (ASPR) is leading a whole-of-nation effort to build that readiness. Drawing on lessons from COVID-19 and other emergencies, ASPR is working with manufacturers and government partners to identify supply-chain vulnerabilities, strengthen resilience planning, and expand domestic manufacturing capabilities so essential products remain available when Americans need them. Together, these efforts support domestic manufacturing and reliable access to essential medicines, advancing goals outlined in President Trump’s Executive Order 13944 and Executive Order 14336.

Working with industry across the medical supply chain

Building resilience requires government and industry to understand where essential medicines are made, what could interrupt their production, and what it takes to keep them available. Manufacturers bring knowledge of their operations, suppliers, and customers. Government can help identify broader vulnerabilities and coordinate preparedness efforts across companies and federal agencies.

ASPR’s Center for Industrial Base Management and Supply Chain (IBMSC) is working with industry to examine these dependencies across the production chain, from key starting materials and active pharmaceutical ingredients to finished medicines. These efforts help identify where additional domestic capability can reduce a single point of failure or dependence on a vulnerable foreign source.

Seeing where disruptions could affect Americans

IBMSC is mapping manufacturing plants throughout the United States to identify where medical products are made and how disruptions could affect their supply. When a hurricane is predicted, ASPR can identify facilities and products within the projected impact zone, supporting earlier coordination with manufacturers and federal partners.

This assessment also considers manufacturers elsewhere that depend on ingredients or supplies from affected locations. A plant elsewhere may depend on ingredients or supplies from an affected location. Understanding those connections helps government and industry plan for the consequences across the supply chain.

Planning for continued production during disruptions

Resilience planning starts with practical questions. If a hurricane closes a plant, where can production continue? If a critical supplier stops operating, what other sources are available? How will a manufacturer maintain operations if workers cannot reach the facility?

Answering those questions before an emergency gives manufacturers a stronger basis for protecting production. A workable plan accounts for trained personnel, reliable inputs, and the quality systems needed to produce medicines safely. Alternative manufacturing arrangements also need to account for the equipment and regulatory requirements of the product being made.

Geographic diversification can reduce the risk that one event interrupts all available production. Additional lines at the same site may be exposed to the same flood or power outage. Capabilities at different locations, including arrangements with other manufacturers, can provide alternatives when a primary facility is unavailable.

Building resilience into federal manufacturing award

ASPR has built these resilience measures into federal manufacturing contracts and agreements supported through IBMSC and the Biomedical Advanced Research and Development Authority (BARDA). These measures put the broader preparedness goals into practice where federal dollars support manufacturing capability.

Entities receiving support through these manufacturing investments are expected to have resilience plans in place, consistent with the terms of their contracts or agreements. When the government needs a manufacturer to activate or increase production, additional support can fund that work. In return, the partner must be able to bring the needed capability into operation when called upon, consistent with its agreement. These expectations help protect taxpayer investments by connecting federal support to the manufacturing capability the nation needs.

Sustaining readiness between emergencies

Preparing manufacturers to respond during an emergency also requires sustaining their capabilities between emergencies. Resilience plans and response commitments depend on having trained workers, reliable suppliers, and production systems ready when needed. To support that readiness, ASPR established the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) through BARDA. The consortium brings together partners across the biopharmaceutical supply chain to expand and reserve manufacturing capacity, strengthen access to critical supplies, and advance manufacturing technologies.

Keeping those capabilities available overtime also requires viable business operations. Manufacturers need ongoing demand to retain experienced workers and maintain production systems. IBMSC is examining how more predictable demand and coordination among federal purchasers could help sustain domestic production, giving manufacturers greater confidence to invest in capabilities that serve both routine healthcare needs and emergency response.

Sustaining production is also central to IBMSC initiatives such as ReShoreRx, the Strategic API Reserve, and EQUIP-A-Pharma. Learn more about these initiatives in ASPR’s September 21 blog, Strengthening America’s Pharmaceutical Supply Chain: How IBMSC Is Building a More Resilient Future.

Lasting preparedness depends on government and industry planning together before a disruption occurs. Stronger domestic production, fewer vulnerable dependencies on foreign sources, and practical plans to keep products available help protect Americans and strengthen national security.

 

Image
Person's hand holding a mobile phone reading a news website.
If you need more information or would like to request a media interview, please contact our media team.
Image
Woman using her mobile phone
Sign Up to Receive the Latest News from ASPR.

Blog Archive